Menarini News / 4

“Telltale” cells in the blood to fight Coronavirus: Fondazione Menarini organises an online congress together with the scientific community

The Menarini International Foundation at the forefront of promoting the culture of prevention and scientific education on COVID-19. A simple blood test could help detect which patients are most at risk of developing serious forms of COVID-19 beforehand. This is the purpose of an experimental study underway at the University of Milan Luigi Sacco Hospital []

trending_flat Read more

Menarini lands in America acquiring the biopharmaceutical company Stemline Therapeutics Inc.

Menarini acquires the U.S. biopharmaceutical company Stemline Therapeutics, focused on the development and commercialization of novel oncology therapeutics. The transaction for this Company – previously listed on Nasdaq – was already announced in early May 2020 and then completed in early June for an aggregate cash consideration up to $ 677 million. Menarini in America []

trending_flat Read more

A new achievement for Menarini: the Sars-Cov-2 diagnostic kit that provides results in 20 minutes

The agreement signed on April 2nd between A. Menarini Diagnostics and Credo Diagnostics Biomedical establishes the exclusive distribution in most European countries of the Sars-Cov-2 diagnostic kit and other tests for the detection of respiratory infections. These kits will be run on VitaPCR ™, a portable platform that delivers results in 20 minutes. The World []

trending_flat Read more